메뉴 건너뛰기




Volumn 76, Issue 2, 1990, Pages 295-300

Long‐term trial with the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one (L1) I. IRON CHELATION AND METABOLIC STUDIES

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE;

EID: 0025018222     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1990.tb07887.x     Document Type: Article
Times cited : (121)

References (29)
  • 4
    • 85004724432 scopus 로고
    • Pharmacological studies of the orally active iron chelator 1,2‐dimethyl‐3‐hydroxy‐pyrid‐4‐one (L1) in man. Abstracts of the 1st International Symposium on Oral Chelation in the Treatment of Thalussaemia and Other Diseases, London. p.
    • (1989) , pp. 38
    • Coddard, J.G.1    Kontoghiorghes, C.J.2
  • 7
    • 85004756527 scopus 로고
    • The design of orally active iron chelators for the treatment of thalassaemia. Ph.D. thesis, Essex University,. British Library Microfilm D66194/86.
    • (1982)
    • Kontoghiorghes, G.J.1
  • 12
    • 85004724318 scopus 로고
    • Properties of the oral chelator 1.2‐dimethyl‐3‐hydroxypyrid‐4‐one (L1) and its effective use in the treatment of transfusional iron overload in thalassaemia. Annals of the New York Academy of Sciences (in press).
    • (1990)
    • Kontoghiorghes, G.J.1
  • 21
    • 85004778294 scopus 로고
    • Preliminary Histopathological results of the effects of subacute doses of L1 in normal and iron loaded rats. Abstracts of the 1st lnternational Symposium on Oral Chelation in the Treatment of Thalassaemia and Other Diseases, London. p.
    • (1989) , pp. 37
    • Matsakis, M.1    Nasseri‐Sina, P.2    Kontoghiorghes, G.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.